Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19

Liang Chen1, Wei Hu2, Xiaoxiao Guo2

  • 1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Scientific Reports
|February 25, 2021
PubMed

Insights

Cardiac injury is a common COVID-19 complication linked to poor outcomes. This study found coagulation dysfunction, particularly elevated D-dimer levels, significantly associated with cardiac injury and mortality in hospitalized patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Hematology

Background:

  • Cardiac injury is a frequent complication of coronavirus disease 2019 (COVID-19).
  • It is associated with adverse clinical outcomes and increased in-hospital mortality.
  • The relationship between cardiac injury and coagulation dysfunction in COVID-19 requires further elucidation.

Purpose of the Study:

  • To investigate the association between cardiac injury and coagulation dysfunction in patients hospitalized with COVID-19.
  • To identify risk factors for cardiac injury and in-hospital mortality in this cohort.
  • To explore the role of coagulation parameters in the pathogenesis of COVID-19-related cardiac injury.

Main Methods:

  • Retrospective analysis of 181 consecutive hospitalized COVID-19 patients.
  • Assessment of cardiac biomarkers: high-sensitivity troponin I (hs-cTnI), myoglobin, and creatine kinase-myocardial band (CK-MB).
  • Evaluation of clinical characteristics, coagulation parameters (including D-dimer), and in-hospital outcomes (discharge or death).

Main Results:

  • Cardiac injury was present in 23.2% of patients.
  • Old age, high leukocyte count, elevated aspartate transaminase (AST), D-dimer, and serum ferritin were significantly associated with cardiac injury.
  • Old age and elevated D-dimer were independent predictors of in-hospital mortality. Interleukin-6 (IL-6) levels were not significantly different between groups.
  • Progressive cardiac injury showed synchronous alterations with D-dimer levels.

Conclusions:

  • Cardiac injury is a common complication of COVID-19 and an independent risk factor for in-hospital mortality.
  • Coagulation dysfunction, particularly elevated D-dimer, plays a significant role in the pathogenesis of cardiac injury in COVID-19, potentially involving microvascular injury.
  • Risk stratification for cardiac injury and mortality should consider age and coagulation parameters like D-dimer.

Related Concept Videos

Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.7K
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
619
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
131
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
183
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.7K